In our recent studies, the inhibition of survivin expression by TAS106 was thought to mainly contribute to the radiosensitisation of apoptosis and the suppression of tumour growth in vitro and in vivo (Inanami et al, 2004; Yasui et al, 2007). The gene discussed is BIRC5; the disease is neoplasm.